1-3 of 3
Thomas Luft
Close
Sort by
Journal Articles

EASIX-1year and late mortality after allogeneic stem cell transplantation

Clinical Trials & Observations
Lambros Kordelas, Tobias Terzer, Ted Gooley, Chris Davis, Brenda M. Sandmaier, Mohamed Sorror, Olaf Penack, Nigel D. E. Schaeper, Igor W. Blau, Dietrich Beelen, Aleksandar Radujkovic, Peter Dreger, Thomas Luft
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5374–5381.
https://doi.org/10.1182/bloodadvances.2022008617
Published: 2023
Includes: Supplemental data
Journal Articles

A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation

Clinical Trials & Observations
Nico Gagelmann, Anita Badbaran, Dietrich W. Beelen, Rachel B. Salit, Friedrich Stölzel, Christina Rautenberg, Heiko Becker, Aleksandar Radujkovic, Victoria Panagiota, Rashit Bogdanov, Maximilian Christopeit, Yong Park, Olivier Nibourel, Thomas Luft, Michael Koldehoff, Maarten Corsten, Michael Heuser, Jürgen Finke, Guido Kobbe, Uwe Platzbecker, Marie Robin, Bart L. Scott, Nicolaus Kröger
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1760–1769.
https://doi.org/10.1182/bloodadvances.2020003600
Published: 2021
Includes: Supplemental data
Journal Articles

CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison

Clinical Trials & Observations
Peter Dreger, Sascha Dietrich, Maria-Luisa Schubert, Lorenz Selberg, Andrea Bondong, Mandy Wegner, Peter Stadtherr, Christoph Kimmich, Florentina Kosely, Anita Schmitt, Petra Pavel, Nora Liebers, Thomas Luft, Ute Hegenbart, Aleksandar Radujkovic, Anthony Dick Ho, Carsten Müller-Tidow, Michael Schmitt
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6157–6168.
https://doi.org/10.1182/bloodadvances.2020003036
Published: 2020
Includes: Supplemental data